Efficacy of Danlou Tablet in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Placebo-Controlled, Randomized Trial

Efficacy of Danlou Tablet in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Placebo-Controlled, Randomized Trial

This study seeks to investigate potential cardioprotection of Danlou Tablets in patients undergoing PCI with non-ST elevation acute coronary syndrome (NSTE-ACS). 219 patients with NSTE-ACS were randomised to Danlou Tablet pretreatment (n=109) or placebo (n=110). No patients received statins prior to...

Full description

Bibliographic Details
Main Authors:	Lei Wang, Xujie Zhao, Shuai Mao, Shaonan Liu, Xinfeng Guo, Liheng Guo, Tinghai Du, Haiyu Yang, Fuhai Zhao, Keng Wu, Hongliang Cong, Yang Wu, Phillip C. Yang, Keji Chen, Minzhou Zhang
Format:	Article
Language:	English
Published:	Hindawi Limited 2016-01-01
Series:	Evidence-Based Complementary and Alternative Medicine
Online Access:	http://dx.doi.org/10.1155/2016/7960503

Similar Items

The effect of Xinkeshu tablets on depression and anxiety symptoms in patients with coronary artery disease: Results from a double-blind, randomized, placebo-controlled study
by: Huan Ma, et al.
Published: (2019-04-01)

Danlou Tablets Inhibit Atherosclerosis in Apolipoprotein E-Deficient Mice by Inducing Macrophage Autophagy: The Role of the PI3K-Akt-mTOR Pathway
by: Chunping Liu, et al.
Published: (2021-09-01)

Clinical and Epidemiological Investigation of TCM Syndromes of Patients with Coronary Heart Disease in China
by: Yi Ren, et al.
Published: (2012-01-01)

Clinical Pathways Based on Integrative Medicine in Chinese Hospitals Improve Treatment Outcomes for Patients with Acute Myocardial Infarction: A Multicentre, Nonrandomized Historically Controlled Trial
by: Lei Wang, et al.
Published: (2012-01-01)

Prognostic value of HbA1c for in-hospital and short-term mortality in patients with acute coronary syndrome: a systematic review and meta-analysis
by: Wenjun Pan, et al.
Published: (2019-12-01)

A Double-Blind, Placebo Controlled, Multicentre Study of the Efficacy And Safety of 5-Aminosalicylic Acid Tablets in the Treatment of Ulcerative Colitis
by: LR Sutherland, et al.
Published: (1990-01-01)

Impact of infection in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: insight from a multicentre observational cohort from China
by: Wei Chen, et al.
Published: (2020-09-01)

Apocynum Tablet Protects against Cardiac Hypertrophy via Inhibiting AKT and ERK1/2 Phosphorylation after Pressure Overload
by: Jianyong Qi, et al.
Published: (2014-01-01)

Clinical Study for Safety Evaluation of GXN Tablets Combined with Aspirin in Long-Term Treatment of Coronary Heart Disease
by: Mingjie Zi, et al.
Published: (2021-01-01)

Coronary plaque property evaluation by coronary CTA and its correlation with inflammatory molecules and MMPs/TIMPs
by: Wen-Bing Yang, et al.
Published: (2017-11-01)

Mid-term follow-up outcomes of 2-staged hybrid coronary revascularization compared with off-pump coronary artery bypass for patients with multivessel coronary artery disease
by: Song Wu, et al.
Published: (2017-03-01)

Effectiveness and safety of Chinese herbal medicine xuanbi antong granules for the treatment of borderline coronary lesions: study protocol for a randomised, double-blinded, placebo-controlled, multicentre clinical trial
by: Mingyan Huang, et al.
Published: (2019-08-01)

Correlation between earlobe crease and coronary artery disease in Indian population- A multicentre experience
by: Vikas Mishra, et al.
Published: (2020-01-01)

Sex-specific assessment of reduced coronary sinus flow in non-hypertensive patients with coronary artery disease at rest
by: Xiao-Zhi Zheng, et al.
Published: (2013-07-01)

A Multicentre Randomized Clinical Trial on Efficacy and Safety of Huxin Formula in Patients Undergoing Percutaneous Coronary Intervention
by: Huan-Lin Wu, et al.
Published: (2014-01-01)

Feasibility and performance of a device for automatic self-detection of symptomatic acute coronary artery occlusion in outpatients with coronary artery disease: a multicentre observational study
by: Frederic Van Heuverswyn, MD, et al.
Published: (2019-06-01)

The Efficacy and Safety of Compound Danshen Dripping Pill Combined with Percutaneous Coronary Intervention for Coronary Heart Disease
by: Cailan Li, et al.
Published: (2020-01-01)

Coronary Artery Diameter is Inversely Associated with the Severity of Coronary Lesions in Patients Undergoing Coronary Angiography
by: Fang-Fang Zhou, et al.
Published: (2017-10-01)

Multicentre cohort study of the impact of percutaneous coronary intervention on patients with concurrent cancer and ischaemic heart disease
by: Tatsuya Nishikawa, et al.
Published: (2021-04-01)

A Precise Prediction Method for the Properties of API-Containing Tablets Based on Data from Placebo Tablets
by: Yoshihiro Hayashi, et al.
Published: (2020-06-01)

A survey of patient preferences for a placebo orodispersible tablet
by: Wade AG, et al.
Published: (2012-03-01)

Clinical implication of coronary tortuosity in patients with coronary artery disease.
by: Yang Li, et al.
Published: (2011-01-01)

Two-Year Outcomes after Left Main Coronary Artery Percutaneous Coronary Intervention in Patients Presenting with Acute Coronary Syndrome
by: Si-Da Jia, et al.
Published: (2020-01-01)

Anomalous left coronary artery with single ostium (Shared with Right Coronary Artery) detected by echocardiography: Two case reports
by: Yingjie Zhao, et al.
Published: (2018-01-01)

Obtuse marginal coronary artery aneurysm on CT coronary angiogram
by: Angel I.Y. Wu, et al.
Published: (2018-10-01)

Acute Effects of Particulate Air Pollution on the Incidence of Coronary Heart Disease in Shanghai, China.
by: Xiaofang Ye, et al.
Published: (2016-01-01)

Inhibition of vascular remodelling in a porcine coronary injury model by herbal extract XS0601
by: Chen Keji, et al.
Published: (2006-11-01)

Optical coherence tomography evaluating the culprit coronary lesion
by: Jin-Chuan Yan, et al.
Published: (2016-01-01)

Impact of coronary tortuosity on coronary pressure: numerical simulation study.
by: Yang Li, et al.
Published: (2012-01-01)

The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease
by: Rabinovich Yevgeny A, et al.
Published: (2010-10-01)

Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study
by: Ling Zhang, et al.
Published: (2021-09-01)

The Active Compounds of Yixin Ningshen Tablet and Their Potential Action Mechanism in Treating Coronary Heart Disease- A Network Pharmacology and Proteomics Approach
by: Xing Lv, et al.
Published: (2020-01-01)

Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial
by: Jun-Bo Ge, et al.
Published: (2021-01-01)

Effects of sugammadex on the coronary circulation: direct effects on coronary vessels or hypersensitivity (Kounis syndrome)?
by: Hong-Seuk Yang, et al.
Published: (2017-06-01)

Evaluation value of coronary CTA for coronary plaque features and its correlation with platelet function and serum biochemical indexes
by: Jin-Xia Yang
Published: (2017-01-01)

Patients with New-Onset Tumor of Severe Coronary Artery Disease May be at a Higher Risk of Arrhythmia
by: Palisha Alimu, et al.
Published: (2021-01-01)

Serial coronary computed tomography angiography-verified coronary plaque progression: comparison of stented patients with or without diabetes
by: Rui Shi, et al.
Published: (2019-09-01)

Effect of Lifestyle Changes after Percutaneous Coronary Intervention on Revascularization
by: Yang Wang, et al.
Published: (2020-01-01)

Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention
by: H. Zhang, et al.
Published: (2021-06-01)

Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical Trial
by: Dong Huang, et al.
Published: (2021-08-01)